Iron out KRAS-driven cancer

被引:2
|
作者
Lei, Guang [1 ,2 ,3 ]
Gan, Boyi [3 ]
机构
[1] Cent South Univ, Hunan Canc Hosp, Dept Radiat Oncol, Changsha, Hunan, Peoples R China
[2] Cent South Univ, Affiliated Canc Hosp, Xiangya Sch Med, Changsha, Hunan, Peoples R China
[3] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 2022年 / 219卷 / 04期
关键词
D O I
10.1084/jem.20212166
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
How to specifically target oncogenic KRAS-driven cancers while sparing normal tissues remains an unmet need in cancer therapy. In this issue of JEM, Jiang et al. (2022. J. Exp. Med.) leveraged KRAS-induced iron addiction in cancer cells to design a clever drug delivery approach to enable selective inhibition of KRAS signaling in mutant KRAS tumors but not in normal tissues, offering a new strategy for treating this largely incurable disease.
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Loss of KDM5A supports KRAS-driven pancreatic cancer
    Chen, Jasper R.
    Han, Jincheng
    Taniguchi, Cullen M.
    DePinho, Ronald A.
    CANCER RESEARCH, 2023, 83 (07)
  • [22] Function for TRP1 in a model of Kras-driven lung cancer
    Ritzmann, F.
    Weichert, C.
    Kamyschnikow, A.
    Bals, R.
    Beisswenger, C.
    PNEUMOLOGIE, 2022, 76 : S13 - S13
  • [23] Loss of KDM5A supports KRAS-driven pancreatic cancer
    Chen, Jasper
    Han, Jincheng
    DePinho, Ronald A.
    Taniguchi, Cullen M.
    CANCER RESEARCH, 2024, 84 (02)
  • [24] KRAS-Driven Metabolic Rewiring Reveals Novel Actionable Targets in Cancer
    Pupo, Emanuela
    Avanzato, Daniele
    Middonti, Emanuele
    Bussolino, Federico
    Lanzetti, Letizia
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [25] KRAS-driven ROS promote malignant transformation
    Suh, Yongjoon
    Lee, Su-Jae
    MOLECULAR & CELLULAR ONCOLOGY, 2015, 2 (01):
  • [26] The Key Role of Calmodulin in KRAS-Driven Adenocarcinomas
    Nussinov, Ruth
    Muratcioglu, Serena
    Tsai, Chung-Jung
    Jang, Hyunbum
    Gursoy, Attila
    Keskin, Ozlem
    MOLECULAR CANCER RESEARCH, 2015, 13 (09) : 1265 - 1273
  • [27] Developing combinatorial therapies for KRAS-driven cancers
    Cichowski, Karen
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [28] CREB is required for KRAS-driven lung tumorigenesis
    Lee, Jong Woo
    Slack, Frank J.
    Nestler, Eric J.
    Herbst, Roy S.
    Koo, Jaseok Peter
    CANCER RESEARCH, 2018, 78 (13)
  • [29] Targeting the MAPK Pathway in KRAS-Driven Tumors
    Drosten, Matthias
    Barbacid, Mariano
    CANCER CELL, 2020, 37 (04) : 543 - 550
  • [30] PKCε Is Required for KRAS-Driven Lung Tumorigenesis
    Garg, Rachana
    Cooke, Mariana
    Benavides, Fernando
    Abba, Martin C.
    Cicchini, Michelle
    Feldser, David M.
    Kazanietz, Marcelo G.
    CANCER RESEARCH, 2020, 80 (23) : 5166 - 5173